SNOA News and Press, Sonoma Pharmaceuticals Inc. From 11/14/19

Sonoma Pharmaceuticals (NASDAQ: SNOA ): Q2 net loss of $1.2M Revenue of $4.96M (+0.4% Y/Y) beats by $0.26M . Press Release More news on: Sonoma Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, ,

Quarterly and YTD Reduction in Net Loss Compared to Prior Year PETALUMA, Calif., Nov. 14, 2019 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a specialty pharmaceutical company dedicated to identifying, developing and commercializing unique, differentiated therapies ...

Sonoma Pharmaceuticals (NASDAQ: SNOA ): Q1 GAAP EPS of $0.54 beats by $2.33 . More news on: Sonoma Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

Strong Quarter-Over-Quarter Performance 26% Increase in U.S. Product Revenue 46% Increase in Dermatology Revenue 23% Reduction in Operating Expenses PETALUMA, Calif., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a specialty pharmaceutical ...

PETALUMA, Calif., July 12, 2019 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a specialty pharmaceutical company dedicated to identifying, developing and commercializing unique, differentiated therapies to millions of patients living with chronic skin conditions, today an...

Sonoma Pharmaceuticals (NASDAQ: SNOA ): Q4 GAAP EPS of -$2.45 misses by $0.66 . More news on: Sonoma Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

Strong Annual Year-Over-Year Growth with 14% Revenue Growth Strong Quarter-Over-Quarter Growth with 20% Revenue Growth and 25% Reduction in Expenses Reduction in Annual Year-Over-Year Net Loss by 18% PETALUMA, Calif., July 08, 2019 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, In...

PETALUMA, Calif., June 19, 2019 (GLOBE NEWSWIRE) -- Specialty pharmaceutical company Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), today announced the timing for a 1-for-9 reverse split of its outstanding common stock which will be effected on June 19, 2019 at 5:00 pm EDT. Sonoma common stoc...

PETALUMA, Calif., May 21, 2019 (GLOBE NEWSWIRE) -- Specialty pharmaceutical company Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), today announced the sale of certain animal health product rights and assets for the Asian and European markets to Petagon, Limited, an international importer and ...

PETALUMA, Calif., March 12, 2019 (GLOBE NEWSWIRE) -- Specialty pharmaceutical company Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), today announced substantial cost-cutting measures, including reductions to the company’s workforce and management.    The measures come on t...